Cholesterol-lowering Decreased mTOR Complex 2 Signaling and Enhanced Antitumor Immunity
Yanping Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Hyung L. Kim(Cedars-Sinai Medical Center)
Cited by 1
Related Papers
A Comparison of Ku0063794, a Dual mTORC1 and mTORC2 Inhibitor, and Temsirolimus in Preclinical Renal Cell Carcinoma Models
|PLoS ONE|2013|62
Cholesterol-Lowering Intervention Decreases mTOR Complex 2 Signaling and Enhances Antitumor Immunity
|Clinical Cancer Research|2021|30
Co-Colorectal cancer stem cells employ the FADS1/DDA axis to evade NK cell-mediated immunosuppression after co-cultured with NK cells under hypoxia
|International Immunopharmacology|2024|5